GLPwatch
Trials (2101)
Page 14 of 36.
- Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging
- Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
- Effects of Semaglutide on Nicotine Intake
- Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Liraglutide in Healthy Japanese Volunteers
- Treatment of Hypoglycemia Following Gastric Bypass Surgery
- Effects of Exenatide on Motor Function and the Brain
- A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- A Study in Women With Overweight or Obesity to Test Whether Different Doses of BI 456906 Influence the Amount of a Contraceptive in the Blood
- A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
- Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
- The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma
- Preoperative Optimization With Tirzepatide, Ketogenic Diet, or Standard Care Before One Anastomosis Gastric Bypass Surgery
- Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity
- A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions for Different Injection Pens
- Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
- Adiponectin in Patients With Metabolic Disorders
- Effect of Liraglutide on Neural Responses to High Fructose Corn Syrup in Individuals With Obesity.
- A Study of LY3437943 in Postmenopausal Female Participants Who Are Overweight or Obese
- A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes
- Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.
- A Research Study Looking at New Protein-based Tablets in Healthy Male Participants
- Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years
- Impact of Exenatide on Sleep Duration
- Safety and Efficacy of YH14617 in Diabetes Mellitus
- Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects
- Trial of Tirzepatide for the Treatment of Cannabis Use Disorder
- Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion
- Liraglutide as Additional Treatment to Insulin in Patients With Autoimmune Diabetes Mellitus
- Pharmacoscintigraphic Investigation of NN9924 in Healthy Male Subjects
- A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy People
- Chinese, Overweight or Obesity, Real-World Registry Study
- Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass
- A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus in India
- Bariatric Surgery Combined With GLP-1 Receptor Agonists Study
- Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables
- A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden
- In Market Utilisation of Liraglutide Used for Weight Management in the UK: a Study in the CPRD Primary Care Database
- A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Mazdutide as Adjuvant Therapy Following Sleeve Gastrectomy in Severe Obesity
- A Randomized Controlled Trial Comparing the Effectiveness of Different Treatment Options for Weight Management After Discontinuation of Semaglutide and Tirzepatide (GLP1 Transition Trial)
- Fecal Microbiota Transplantation (FMT) Combined With Calorie-Restricted Diet and Semaglutide in Patients With Obesity and Type 2 Diabetes
- Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
- A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects
- A Study to Evaluate the Drug-drug Interactions (DDIs) of IBI362 With Metformin, Warfarin, Atorvastatin, Digoxin in Overweight or Obese Subjects
- A Research Study About Weight Loss and Treatment Patterns With the Use of Saxenda® in Adults in Real-life Settings in Switzerland
- Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome
- Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
- A Study of Orforglipron (LY3502970) to Compare a Single Capsule and Multiple Capsules in Healthy Participants
- Human Bioequivalence Test of Liraglutide Injection
- A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes
- Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes
- Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression
- Effectiveness of Combined GLP-1/GIP Dual Agonist Therapy and Structured Exercise on Skeletal Muscle Morphology, Quality, and Physical Function in Overweight and Obese Individuals
- Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
- The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults
- UBT251 Injection Phase II (Type 2 Diabetes Mellitus) Study
- Incretin-based Drugs and Acute Pancreatitis
- A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)
- Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease